Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Retinal Degeneration Disease_Hollyfield, Anderson, LaVail_1999

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
18.95 Mб
Скачать

436 S. GELLER ET AL.

Casson, R. L., Chidlow, G., Wood, J., Vidal-Sanz, M. and Osborne, N., 2004. The Effect of Retinal Ganglion Cell Injury on Light-Induced Photoreceptor Degeneration. Invest Ophthalmol Vis Sci. 45:685-693.

Chan-Ling, T. and Stone, J., 1993. Retinopathy of prematurity: Origins in the architecture of the retina. Prog Ret Res. 12:155-176.

Duncan, T. and O’Steen, W., 1985. The diurnal susceptibility of rat retinal photoreceptors to light-induced damage. Exp Eye Res. 41:497-507.

Haugh, L., Linsenmeier, R. and Goldstick, T., 1990. Mathematical models of the spatial distribution of retinal oxygen tension and consumption, including changes upon illumination. Annal Biomed Engin. 18:19-36.

Heckenlively, J., 1988. Retinitis Pigmentosa. Lippincott, Philadelphia.

Hicks, D. and Sahel, J., 1999. The implications of rod-dependent cone survival for basic and clinical research. Invest Ophthalmol Vis Sci. 40:3071-3074.

Kostyk, S., D’Amore, P., Herman, I. and Wagner, J., 1994. Optic nerve injury alters basic fibroblast growth factor localisation in the retina and optic tract. J Neurosci. 14:1441-1449.

Lahdenranta, J., Pasqualini, R., Schlingemann, R. O., Hagedorn, M., Stallcup, W. B., Bucana, C. D., Sidman, R. L. and Arap, W., 2001. An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration. Proc Natl Acad Sci U S A. 98:10368-10373.

Linsenmeier, R. A., 1986. Effects of light and dark on oxygen distribution and consumption in the cat retina. J Gen Physiol. 88:521-542.

Linsenmeier, R. A., Padnick-Silver, L., Derwent, J. K., Ramirez, U. and Narfstrom, K., 2000. Changes in photoreceptor oxidative metabolism in Abyssinian cats with heredity rod/cone degeneration. Invest Ophthalmol Vis Sci. 41:S886.

Liu, C., Peng, M. and Wen, R., 1997. Pre-exposure to constant light protects photoreceptor from subsequent light damage in albino rats. Invest Ophthalmol Vis Sci. 38:S718.

Maslim, J., Valter, K., Egensperger, R., Hollander, H. and Stone, J., 1997. Tissue oxygen during a critical developmental period controls the death and survival of photoreceptors. Invest Ophthalmol Vis Sci. 38:16671677.

Mervin, K. and Stone, J., 2002a. Developmental death of photoreceptors in the C57BL/6Jmouse: association with retinal function and self-protection. Exp Eye Res. 75:703-713.

Mervin, K. and Stone, J., 2002b. Regulation by oxygen of photoreceptor death in the developing and adult C57BL/6J mouse. Exp Eye Res. 75:715-722.

Mervin, K., Valter, K., Maslim, J., Lewis, G., Fisher, S. and Stone, J., 1999. Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol. 128:155-164.

Noell, W. K., 1955. Visual cell effects of high oxygen pressures. American Physiology Society: Federation Proceedings. 14:107-108.

Penn, J. S., Li, S. and Naash, M. I., 2000. Ambient hypoxia reverses retinal vascular attenuation in a transgenic mouse model of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 41:4007-4013.

Rapp, L. M. and Williams, T. P., 1980. A parametric study of retinal light damage in albino and pigmented rats. The effects of constant light on visual processes. Plenum Press, New York, pp. 135-159.

Sternberg, P., Landers, M. and Wolbarsht, M., 1984. The negative coincidence of retinitis pigmentosa and proliferative diabetic retinopathy. Am J Ophthalmol. 97:788-789.

Stone, J., Itin, A., Alon, T., Pe’er, J., Gnessin, H., Chan-Ling, T. and Keshet, E., 1995. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 15:4738-4747.

Stone, J. and Maslim, J., 1997. Mechanisms of retinal angiogenesis. Prog Ret Eye Res. 16:157-181.

Stone, J., Maslim, J., Valter-Kocsi, K., Mervin, K., Bowers, F., Chu, Y., Barnett, N., Provis, J., Lewis, G., Fisher, S., Bisti, S., Gargini, C., Cervetto, L., Merin, S. and Pe’er, J., 1999. Mechanisms of photoreceptor death and survival in mammalian retina. Prog Ret Eye Res. 18:689-735.

Stone, J., Mervin, K., Walsh, N., Valter, K., Provis, J. and Penfold, P., 2004. Photoreceptor stability and degeneration in mammalian retina: lessons from the edge. In: Penfold, P. and Provis, J. (Eds.), Macular Degeneration: Science and Medicine in Practice. Springer Verlag, pp. (in press).

Valter, K., Maslim, J., Bowers, F. and Stone, J., 1998. Photoreceptor dystrophy in the RCS rat: Roles of oxygen, debris and bFGF. Invest Ophthalmol Vis Sci. 39:2427-2442.

Walsh, N., Bravo-Nuevo, A., Geller, S. and Stone, J., 2004a. Resistance of photoreceptors in the C57BL/6-C2J, C57BL/6J and BALB/CJ mouse strains to oxygen stress: evidence of an oxygen phenotype. Curr Eye Res. In press.

60. HYPEROXIA-INDUCED PHOTORECEPTOR DEATH

437

Walsh, N. and Stone, J., 2001. Timecourse of bFGF and CNTF expression in light-induced photoreceptor degeneration in the rat retina. In: Anderson, R. E. et al. (Eds.), New Insights into Retinal Degenerative Diseases. Kluwer Academic Plenum Publishers, New York, pp. 111-118.

Walsh, N., Valter, K. and Stone, J., 2001. Cellular and subcellular patterns of expression of bFGF and CNTF in the normal and lightstressed adult rat retina. Exp Eye Res,. 72:495-501.

Walsh, N., Van Driel, D., Lee, D. and Stone, J., 2004b. Multiple vulnerability of photoreceptors to mesopic ambient light in the P23H transgenic rat. Brain Research. 1013:194-203.

Yamada, H., Yamada, E., Ando, A., Esumi, N., Bora, N., Saikia, J., Sung, C. H., Zack, D. J. and Campochiaro, P. A., 2001. Fibroblast growth factor-2 decreases hyperoxia-induced photoreceptor cell death in mice. Am J Pathol. 159:1113-1120.

Yu, D. and Cringle, S. J., 2001. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Ret Eye Res. 20:175-208.

Yu, D.-Y., Cringle, S., Valter, K., Walsh, N., Lee, D. and Stone, J., 2004. Photoreceptor death, trophic factor expression, retinal oxygen status, and photoreceptor function in the P23H rat. Invest Ophthalmol Vis Sci. 45:20132019.

Yu, D. Y., Cringle, S. J., Su, E. N. and Yu, P. K., 2000. Intraretinal oxygen levels before and after photoreceptor loss in the RCS Rat. Invest Ophthalmol Vis Sci. 41:3999-4006.

CHAPTER 61

TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS DEPRESSES ELECTRORETINOGRAM RESPONSIVENESS IN MICE

Yves Sauvé1, Goutam Karan1,2, Zhenglin Yang1,2, Chunmei Li1,2,

Jianbin Hu1,2, and Kang Zhang1,2,3

1. INTRODUCTION

We showed that a functional complex of CA4 and Na+/bicarbonate co-transporter (NBC1) is specifically expressed in the choriocapillaris and that mutations in CA4 disrupt NBC1-mediated HCO3- transport leading to acidification of the retina. This finding (Yang et al., 2005) point to the importance of a functional CA4 for the survival of photoreceptors and imply that CA inhibitors may have long-term adverse effects on vision.

Carbonic anhydrase inhibitors, (CAIs) have a wide range of clinical applications; indications include glaucoma, macular edema (a frequent complication of RP), acute mountain sickness, seizure, increased intracranial pressure, and fluid reduction/diuresis (Weisbecker et al., 2002). Acetazolamide is one of the most extensively used CAIs, and is given frequently as an oral dosage of 1000 mg once daily. At this dosing regimen, it produces a serum trough and peak range of 12-30 mg/ml, or 54 mM to 135 mM in concentration (Friedland et al., 1977). The IC50 of the membrane-associated carbonic anhydrase type 4 (CA4), is 4 mM (Ives, 1998). The Ki of acetazolamide for CA4, is 70 nM (Ilies et al., 2003), therefore, current carbonic anhydrase inhibitors will almost fully inhibit CA4 enzymatic activity. A study of healthy volunteers showed that a single dose of 500 mg of acetazolamide causes demonstrable changes in tests of color vision (Leys et al., 1996). In addition, light-adapted electroretinograms (ERG) a-waves in humans are attenuated about 14% by acetazolamide (Odom et al., 1994). Consequently, the use of CAIs may impair photoreceptor function.

1 Department of Ophthalmology and Visual Science, University of Utah Health Science Center, Salt Lake City, UT 84132, USA.

2 Program in Human Molecular Biology and Genetics, Eccles Institute of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.

3 Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT 84112, USA.

439

440

Y. SAUVÉ ET AL.

We investigated the effect of acetazolamide on retina function by measuring the ERG in mice treated with acetazolamide. We observed that ERG findings in acetazolamide treated mice were analogous to those in human patients with the autosomal dominant rod-cone dystrophy RP17 (Yang et al., 2005). Therefore we caution that long term use of carbonic anhydrase inhibitors may have potential detrimental effects on photoreceptor cells and vision.

2. METHODS

2.1. Animals and Treatment

Mice were housed and handled with the authorization and supervision of the Institutional Animal Care and Use Committee from the University of Utah. Every procedure conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Blk6 mice of 2-3 month of age were given intraperitoneal injections of either normal saline (control group) or acetazolamide at doses of 5, 10, 20, and 30 mg/100 g body weight at a volume of 150 ml at day 0, and day 4 (n = 6 per group). ERG was recorded at day 7.

2.2. ERG Recordings

Under anesthesia with a mixture of ketamine (150 mg/kg i.p.) and xylazine (10 mg/kg i.p.), the mouse head was secured with a stereotaxic head holder and the body temperature monitored through a rectal thermometer and maintained at 38°C using a homeothermic blanket. Pupils were dilated using equal parts of topical phenylephrine (2.5%) and tropicamide (1%). Bupivacaine 0.5% was used as a topical anesthetic to avoid blinking and a drop of 0.9% saline was frequently applied on the cornea to prevent its dehydration and allow electrical contact with the recording electrode (gold wire loop). A platinum subdermal needle (Grass Telefactor, F-E2) inserted under the scalp, between the two eyes, served as the reference electrode. Amplification (at 1-1000 Hz bandpass, without notch filtering), stimulus presentation, and data acquisition were provided by the UTAS-3000 system from LKC Technologies (Gaithersburg, MD).

For dark-adapted ERG recordings, tests consisted of single flash presentations (10 msec duration), repeated 3 to 5 times to verify the response reliability and improve the signal-to- noise ratio, if required. Stimuli were presented at sixteen increasing intensities in one log unit steps varying from -3.6 to 1.4 log cds/m2 in luminance. To minimize the potential bleaching of rods, inter-stimulus intervals were increased as the stimulus luminance was elevated from 10 sec at lowest stimulus intensity up to 2 minutes at highest stimulus intensity.

Following dark-adapted recordings, the animals were light adapted for 15 minutes to assure maximal cone output. Photopic intensity responses (30 cds/m2 background) ranged from -1.6 to 2.9 log cds/m2 (-1.6, -0.6, 0.4, 1.4, 2.4 and 2.9 log cds/m2). Criteria responses were set at 20 mV for a- and b-waves (under scotopic and photopic adaptation). For flicker ERGs, stimuli consisted of white flashes provided by a xenon bulb (luminance of 1.37 log cds/m2), projected on a ganzfeld with a background luminance of 30 cds/m2 presented at 20 Hz. The stimulus was presented during 3 seconds prior to data collection. This guaranteed that the first few responses (not preceded by repeated stimuli and of potentially greater amplitude) were not included in the average. A total of 40 responses were averaged.

61. DECREASED ERG IN ACETAZOLAMIDE TREATED MICE

441

The amplitude of the flicker response was defined as the average of the difference between consecutive negative and positive deflections.

2.3. Statistical Analysis

Error values accompanying averages were expressed as standard errors of the mean (SEM). Comparisons between two groups were made using Mann-Whitney U-test. The probability level at which the Null Hypothesis was rejected is represented as the value “p”; statistical significance was set at p < 0.05.

3. RESULTS

Acetazolamide treatment resulted in a depression of both coneand rod-mediated ERG responses, in a dose dependent manner. However, dose dependence differed for cone and rod-related responses; cone related responses were affected at lower dose regimens than rod related responses.

The two lowest dose regimens, studied here, led to depressed cone mediated responses. Photopic b-wave amplitudes at high luminance stimuli under photopic adaptation (Fig. 61.1), as well as cone-mediated 20 Hz flicker amplitudes (Fig. 61.2) were significantly reduced following 5 and 10 mg/100 g acetazolamide treatment. There were tendencies for amplitude reductions at 20 and 30 mg/100 g doses, especially for maximal photopic b-wave amplitudes, but these reductions did not reach statistical significance. Optimal amplitude reductions occurred for the 10 mg/100 g dosage, both for photopic b-waves and 20 Hz flicker. At this dosage, statistically significant reductions in photopic b-wave amplitudes were seen for stimuli of 0.88 log cds/m2 and higher. Photopic b-wave thresholds remained unaffected by acetazolamide, regardless of its dose, and b- amplitudes constantly reached a plateau for stimuli of 1.89 log cds/m2 and of higher luminances.

The results for scotopic ERGs are presented in Fig. 61.3. Statistically significant reductions in scotopic ERG responses (for both maximal a- and b-wave amplitudes) were only obtained with the highest dose regimen, i.e. 30 mg/100 g acetazolamide (Figure 61.3A). In two animals treated at this dosage (scotopic intensity response traces from one of which are presented in Figure 61.3B), the thresholds for a- and b-waves were higher than in PBS injected animals. However, there were no statistically significant changes between acetazolamide (30 mg/100 g) and PBS treated groups. Statistically significant reductions in a- and b-wave amplitudes were seen for stimuli higher than 1.37 log cds/m2 and 0.88 log cds/m2, respectively. There was a significant drop in b-wave amplitudes at the highest luminance tested (326 ± 34 mV at 2.86 log cds/m2) compared with the luminance giving the maximal b-wave amplitude (434 ± 36 at 1.89 log cds/m2). This indication of bleaching was not seen in PBS treated animals.

4. DISCUSSION

This study shows that mice treated with acetazolamide have reduced rod and cone related ERG responsiveness. Treatment with two i.p. injections of 5 or 10 mg/100g (at day 0 and day 4) led to a reduction at day 7 in cone related ERG responses, as reflected by

442

A

(µV)

300

 

 

 

 

 

 

 

 

 

 

 

 

 

amplitude

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

200

 

 

*

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-wave

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

b

 

 

 

 

 

 

 

 

 

 

 

 

 

 

maximal

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PBS

5 mg AZM 1 0 mg AZM 2 0 mg AZM 3 0 mg AZM

 

 

 

B

2.86 2.39 1.89

1.37 0.88

0.38 -0.02

-0.42 -0.81

-1.22 -1.63

C

photopic b-wave amplitude (µV)

250

200

150

100

50

0

-2

PBS

*

1 0 mg AZM

 

*

-1 0 1 luminance (log cds/m2)

µV 200

50msec

* * *

23

Y. SAUVÉ ET AL.

Figure 61.1. Effect of acetazolamide treatment on cone-related ERG responses using single flashes with background adaptation (30 cd/m2) that saturates rods. Panel A gives the maximal photopic b-wave amplitude at 7 days following treatment with PBS and various doses of acetazolamide (AZM). Examples of intensity response traces for mice treated with PBS (left side) or 10 mg/100 g AZM (right side) are illustrated in panel B; flash intensities are indicated as log cds/m2 on the right of the traces. Finally, photopic intensity response curves for saline and acetazolamide (10 mg/100 g) treated mice are presented in panel C. Statistically significant differences are indicated by an asterisk (*).

A

100

(µV)

 

 

 

 

*

 

 

 

 

 

 

 

 

 

 

amplitude

50

 

 

 

*

 

 

 

 

 

 

 

 

 

75

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

flicker

25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20Hz

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PBS

5mg AZM 10mg AZM 20mg AZM 30mg AZM

 

 

 

B

 

 

 

 

 

 

 

 

 

 

 

50 msec

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

µV 100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

saline

 

 

acetazolamide (10mg/100g)

Figure 61.2. Effect of acetazolamide treatment on cone-related ERG responses using 20 Hz flicker stimuli with background adaptation (30 cd/m2) that saturates rods. Panel A gives the maximal amplitude at 7 days following treatment with PBS and various doses of acetazolamide (AZM). Examples of 20 Hz flicker traces are illustrated in panel B; amplitudes for traces from saline and acetazolamide (10 mg/100 g) treated mice are 94 and 41 mV respectively. Statistically significant differences are indicated by an asterisk (*).

61. DECREASED ERG IN ACETAZOLAMIDE TREATED MICE

A

(µV)

 

 

 

 

 

 

 

 

 

 

 

 

 

(µV)

800

 

 

 

 

 

500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

amplitude

 

 

 

 

 

 

 

 

 

 

 

 

amplitude

 

 

 

 

 

300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

400

 

 

 

 

 

 

 

 

 

 

 

 

 

600

 

 

 

 

 

wave-a

200

 

 

 

 

 

 

 

 

 

 

 

*

wave-b

400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

maximal

100

 

PBS

 

AZM5mg

 

AZM10mg

 

AZM20mg

 

AZM30mg

maximal

 

 

PBS

 

AZM5mg

 

0

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

443

 

 

 

 

 

 

*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AZM 10mg

 

AZM 20mg

 

AZM 30mg

B

2.86

2.39

1.89

1.37

0.88

0.38

-0.02

-0.42

-0.81

-1.22

-1.63

-2.04 -2.44 -2.82 -3.22 -3.70

C

400

 

 

***

(µV)

 

 

300

 

 

amplitude

 

PBS

 

 

 

200

30mg AZM

 

 

wave-a

 

 

 

100

 

 

 

 

 

 

 

 

0

 

 

 

 

-4

-2

0

2

luminance (log cds/m2)

µV 400

50 msec

(µV)

600

 

 

****

450

PBS

 

amplitude

30mg AZM

 

 

300

 

 

 

wave-b

 

 

 

150

 

 

 

 

 

 

 

 

0

 

 

 

 

-4

-2

0

2

luminance (log cds/m2)

Figure 61.3. Effect of acetazolamide treatment on mixed scotopic ERG responses. Panel A gives the maximal photopic a- (left side) and b- (right side) wave amplitudes at 7 days following treatment with PBS and various doses of acetazolamide (AZM). Examples of intensity response traces for mice treated with PBS (left side) or 30 mg/100 g AZM (right side) are illustrated in panel B; flash intensities are indicated as log cds/m2 on the right of the traces. Finally, scotopic intensity response curves for saline and acetazolamide (30 mg/100 g) treated mice are presented in panel C; a-wave on left and b-wave on right handside. Statistically significant differences are indicated by an asterisk (*).

diminutions in maximal photopic b-wave and 20 Hz flicker amplitudes. Reduction in rodrelated ERG responses, as reflected by diminutions in maximal a- and b-wave amplitudes of dark-adapted scotopic ERGs, was only seen at higher doses, i.e. 30 mg/100 g. These results partially replicate previous results obtained in similar studies done in rats (Findl et al., 1995) where a treatment regimen of 5 mg/100 g i.p. at day 0 led to decrease in rod and cone related ERG responses at day 3. Our findings are also in accord with previous findings of Broeders et al. (1988) showing decreased rod and cone-mediated a- and b-wave

444 Y. SAUVÉ ET AL.

amplitudes already 5 hours post-injection of another CAI, methazolamide, at 5 mg/100 g i.p. in rabbits. The findings of decreased ERG responses at time points as early as 5 hours indicate that diminution in ERG responses likely occurs without photoreceptor degeneration and, in the case of depressed rod responsiveness, could be related to acute metabolic changes such as involving an acidification of the retina (Findl et al., 1995). In addition, our findings of optimal depression of cone responses at intermediate doses also argue for a specific change in cell function rather than a direct toxic effect of acetazolamide for the 7 days treatment regimen used here: toxicity should not be expected to diminish as the dosage increases. Still, based on recent findings of an RP form involving a dysfunction of CA4, it is a reasonable assumption that long-term inhibition of this enzyme (and possibly other CAs) might lead to photoreceptor degeneration. Direct injections of acetazolamide in the vitreous of rabbits have indicated that doses of 1 mg or higher not only depressed the b-wave but also resulted in damaged outer segments (Borhani et al., 1994). Assuming that this effect is related to the inhibitory action of acetazolamide on CAs, then a complete inhibition should be expected to have deleterious effects. For instance, topical dorzolamide 3%, which is the optimal dose for treating glaucoma in experimental rabbit, produces a concentration of 35 mM in ocular tissues (Sugrue, 1996), which is higher than the IC50 of 4 mM for CA4 (Ives, 1998), implying a complete inhibition of CA4 enzymatic activity.

CAs are expressed in ocular tissues i.e. in choriocapillaris (CA4) and retina (CA2), their enzymatic action involves catalyzing the reaction of carbon dioxide and water to carbonic acid, which dissociates to bicarbonate and hydrogen ions. Therefore, CAs play a crucial role in regulating tissue pH via their ability to increase the effectiveness of the bicarbonate buffer system. The inhibition of CAs reduces the buffering of the acid reflux from photoreceptors resulting in a lowering of the extracellular pH around these cells. Hydrogen ions have been shown to suppress the dark current of rods in frogs (Liebmann et al., 1984), and acidification was shown to depress photoreceptor response in isolated rat retinae (Winkler, 1972). Hydrogen ions, being elevated in concentration following CAI treatment, might attenuate the amplitude of ERG components by competing with Ca++ for binding sites in rods (Moody, 1984) and/or decreasing the Na+/Ca++ exchange in these cells (Hodgkin and Nunn, 1987), both resulting in elevated intracellular Ca++, which is known to downregulate the light sensitive Na+ conductance in rod outer segments via cGMP gated Na+ channels (Yau, 1994). CAIs might also lead to acidification of the retina by acting on Muller cells, which have been shown to play a crucial role in regulating the extracellular pH (Oakley and Wen, 1989). In brief, the depression of rod photoreceptor response following CA inhibition in mice treated in the present study is likely to involve an acidification of the retina.

Our results indicate that cone function is also affected by acetazolamide treatment; furthermore, cone related ERG responses are depressed at lower doses, 10 mg/100 g, instead of 30 mg/100 g required to diminish scotopic responses. This CAI-induced depression of cone ERG might involve mechanisms other than acidification. Psychophysical tests in human treated with the CAI methazolamide revealed a disturbance of color discrimination which was not correlated with the degree of acidosis (Widengard, 1995). CAIs might act directly on cones themselves and only indirectly on rods (via acidification as explained above). Histochemical analysis of human retinae indicates that cones (with the exception of blue cones) contain CA activity, while rods do not (Nork et al., 1990). In addition, Muller cells, which also contain CAs, are involved in the generation of b-waves via K+-evoked depolarization (Wen and Oakley, 1990), and CA inhibition has been shown to modify the extracellular K+ concentration in isolated salamander Muller cells (Newman, 1996). It is

61. DECREASED ERG IN ACETAZOLAMIDE TREATED MICE

445

therefore possible that CAIs might also affect the light induced depolarization of Muller cells, and consequently have an effect on the b-wave amplitude. Finally, acetazolamide decreases the ability of Muller cells for buffering the extracellular fluid compartment (Wen and Oakley, 1990). Changes in fluid balances, such as reported in studies involving mice deficient in the water channel aquaporin-4 (expressed by Muller cells) have been shown to lead to b-wave depression by 10 months of age (Li et al., 2002).

5. CONCLUSIONS

Acetazolamide treatment in mice leads to a depression of both rod and cone related ERG responses as seen in patients with the RP17 rod-cone dystrophy. Therefore, the chronic use of CAIs, particularly pertinent in the treatment of glaucoma, may lead to visual loss, cone function being affected at lower doses than rod function.

6. ACKNOWLEDGEMENTS

This research was supported by National Institutes of Health Grants R01EY14428, R01EY14448 and GCRC M01-RR00064, the Ruth and Milton Steinbach Fund, Ronald McDonald House Charities, the Macular Vision Research Foundation, the Research to Prevent Blindness, Inc., Knights Templar Eye Research Foundation, Grant Ritter Fund, American Health Assistance Foundation, the Karl Kirchgessner Foundation, Val and Edith Green Foundation, and the Simmons Foundation.

7. REFERENCES

Borhani, H., Rahimy, M.H., Peyman, G.A., 1994, Vitreoretinal toxicity of acetazolamide following intravitreal administration in the rabbit eye, Ophthalmic Surg. 25:166-169.

Broeders, G.C., Parmer, R., Dawson, W.W., 1988, Electroretinal changes in the presence of a carbonic anhydrase inhibitor, Ophthalmologica. 196:103-110.

Findl, O., Hansen, R.M., Fulton, A.B., 1995, The effects of acetazolamide on the electroretinographic responses in rats, Invest Ophthalmol Vis Sci. 36:1019-1026.

Friedland, B.R., Mallonee, J., Anderson, D.R., 1977, Short-term dose response characteristics of acetazolamide in man. Arch Ophthalmol. 95: 1809-1812.

Hodgkin, A.L., Nunn, B.J., 1987, The effect of ions on sodium-calcium exchange in salamander rods, J Physiol. 391:371-398.

Ilies, M.A., Vullo, D., Pastorek, J., Scozzafava, A., Ilies, M., Caproiu, M.T., Pastorekova, S., Supuran, C.T., 2003, Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives, J Med Chem. 46:2187-2196.

Ives, H.E., 1998, Diuretic Agents. In Basic & Clinical Pharmacology, B.G.Katzung, ed. (Stamford, CT: Appleton & Lange), pp. 246-248.

Leys, M.J., van Slycken, S., Nork, T.M., Odom, J.V., 1996, Acetazolamide affects performance on the Nagel II anomaloscope, Graefes Arch Clin Exp Ophthalmol. 234 Suppl 1:S193-197.

Li, J., Patil, R.V., Verkman, A.S., 2002, Mildly abnormal retinal function in transgenic mice without Muller cell aquaporin-4 water channels, Invest Ophthalmol Vis Sci. 43:573-579.

Liebman, P.A., Mueller, P., Pugh, E.N. Jr., 1984, Protons suppress the dark current of frog retinal rods, J Physiol. 347:85-110.

446 Y. SAUVÉ ET AL.

Moody, W. Jr., 1984, Effects of intracellular H+ on the electrical properties of excitable cells, Annu Rev Neurosci. 7:257-278.

Newman, E.A., 1996, Acid efflux from retinal glial cells generated by sodium bicarbonate cotransport, J Neurosci. 16:159-168.

Nork, T.M., McCormick, S.A., Chao, G.M., Odom, J.V., 1990, Distribution of carbonic anhydrase among human photoreceptors, Invest Ophthalmol Vis Sci. 31:1451-1458.

Oakley, B. 2nd, Wen, R., 1989, Extracellular pH in the isolated retina of the toad in darkness and during illumination, J Physiol. 419:353-378.

Odom, J.V., Nork, T.M., Schroeder, B.M., Cavender, S.A., van Slycken, S., Leys, M., 1994, The effects of acetazolamide in albino rabbits, pigmented rabbits, and humans, Vision Res. 34:829-8237.

Sugrue, M.F., 1996, The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor, J Ocul Pharmacol Ther. 12:363-376.

Weisbecker, C.A., Fraunfelder, F.T., Tippermann, R., 2002, Physicians’ desk reference for ophthalmic medicines, Montvale, N.J.: Medical Economics Company, Inc.

Wen, R., Oakley, B. 2nd, 1990, K(+)-evoked Muller cell depolarization generates b-wave of electroretinogram in toad retina, Proc Natl Acad Sci U S A. 87:2117-2121.

Widengard, I., Mandahl, A., Tornquist, P., Wistrand, P.J., 1995, Colour vision and side-effects during treatment with methazolamide, Eye. 9:130-135.

Winkler, B.S., 1972, The electroretinogram of the isolated rat retina, Vision Res. 12:1183-1198.

Yang, Z., Alvarez, B.V., Chakarova, C., Jiang, L., Karan, G., Frederick, J.M., Zhao, Y., Sauve, Y., Li, X., Zrenner, E., Wissinger, B., Hollander, A.I., Katz, B., Baehr, W., Cremers, F.P., Casey, J.R., Bhattacharya, S.S., Zhang, K., 2005, Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor degeneration,

Hum Mol Genet. 14:255-265.

Yau, KW., 1994, Phototransduction mechanism in retinal rods and cones. The Friedenwald Lecture, Invest Ophthalmol Vis Sci. 35:9-32.